CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading advisory and ...

CS Diagnostic Corp. is a global healthcare innovation company committed to advancing medical diagnostics through innovation and precision technology. With a strong foundation in research and a global ...

Short interest for CS Diagnostics gives investors a sense of the degree to which investors are betting on the decline of CS Diagnostics's stock. Short interest data is updated every two weeks.

CHEYENNE, WY / ACCESS Newswire / September 24, 2025 / CS Diagnostics Corp. (CSDX) ("CSDX" or "the Company"), a pioneering leader in innovative diagnostic and protective solutions, today announced a ...

NEUSS, GERMANY AND CHEYENNE, WY / ACCESS Newswire / July 16, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) is pleased to announce that it has successfully submitted the final draft of Form F-10 ...

NEUSS, Germany--(BUSINESS WIRE)-- CS Diagnostics Corp. (OTCQB: CSDX) (or “the company”) is delighted to announce the U.S. launch of MEDUSA, alongside its product CS Protect-Hydrogel. MEDUSA is a ...

NEUSS, DE / ACCESS Newswire / June 18, 2025 / CS Diagnostics Corp. (CSDX) a global leader in innovative healthcare solutions announced its participation in the Small Cap Growth Virtual Investor ...

CHEYENNE, WY AND NEUSS, GERMANY / ACCESS Newswire / July 1, 2025 / CS Group announced that its regional subsidiary, CS Interpharm General Trading CO. LLC has signed a Memorandum of Understanding (MOU) ...

CHEYENNE, WY / ACCESS Newswire / September 24, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) ("CSDX" or "the Company"), a pioneering leader in innovative diagnostic and protective solutions, today ...